BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9864411)

  • 1. A polyclonal antibody against synthetic peptide conserved in N-Myc protein reacts with water-soluble recombinant N-Myc protein.
    Yang HW; Hemmi H; Ikeda H; Kato K; Tsuchida Y
    Oncol Rep; 1999; 6(1):107-11. PubMed ID: 9864411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM.
    David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R
    Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a polyclonal antibody with defined specificity against synthetic peptides from the N-myc oncoprotein using multiple antigen peptide and hemocyanin conjugation methods.
    Yang HW; Ikeda H; Kato K; Nakagawara A; Choi SH; Hayashi Y; Obana K; Hemmi H; Tsuchida Y
    J Pediatr Surg; 1999 Mar; 34(3):454-60. PubMed ID: 10211653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant plasmid expressing the entire coding region of the Bmyc putative protein.
    Steinitz M; Ingvarsson S; Asker C; Sümegi J; Klein G
    J Clin Lab Immunol; 1990 Jun; 32(2):49-54. PubMed ID: 1967038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of single chain antibodies (ScFvs) for c-myc oncoprotein in recombinant Escherichia coli membranes by using the ice-nucleation protein of Pseudomonas syringae.
    Bassi AS; Ding DN; Gloor GB; Margaritis A
    Biotechnol Prog; 2000; 16(4):557-63. PubMed ID: 10933828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemistry of the human fetal mesonephros with anti-human N-myc protein antibody].
    Kawahara M; Tsukahara T; Nakagawa C
    Hinyokika Kiyo; 1988 Feb; 34(2):207-14. PubMed ID: 3287857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical processing of amyloid precursor fusion protein by proteolytic activity in Pichia pastoris.
    Markaryan A; Morozova I; Lee BS; Kaplan A
    Biochem Biophys Res Commun; 1999 Aug; 262(1):263-8. PubMed ID: 10448103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human c-myc exon 1 product: preparation of antisera and analysis of its expression.
    Ferré F; Martin P; Lagrou C; Raes MB; Ghysdael J; Saule S; Stéhelin D
    Oncogene; 1987; 1(4):387-93. PubMed ID: 3330782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From IgG monoclonals to IgM-like molecules.
    Ernst M; Meier D; Sonneborn HH
    Hum Antibodies; 1999; 9(3):165-70. PubMed ID: 10690630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing in protein associated with Myc (Pam) influences its binding to c-Myc.
    Santos TM; Han S; Bowser M; Sazani K; Beauchamp RL; Murthy V; Bhide PG; Ramesh V
    J Neurosci Res; 2006 Feb; 83(2):222-32. PubMed ID: 16342205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of polyclonal antibodies against human chaperonin 10.
    Somodevilla-Torres MJ; Hillyard NC; Morton H; Alewood D; Halliday JA; Alewood PF; Vesey DA; Walsh MD; Cavanagh AC
    Cell Stress Chaperones; 2000 Jan; 5(1):14-20. PubMed ID: 10701835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of monoclonal and polyclonal antibodies against human intestinal fatty acid-binding protein (I-FABP) using synthetic regional peptides and recombinant I-FABP.
    Kajiura S; Yashiki T; Funaoka H; Ohkaru Y; Nishikura K; Kanda T; Ajioka Y; Igarashi M; Hatakeyama K; Fujii H
    J Immunoassay Immunochem; 2008; 29(1):19-41. PubMed ID: 18080878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma.
    Hossain MS; Ozaki T; Wang H; Nakagawa A; Takenobu H; Ohira M; Kamijo T; Nakagawara A
    Oncogene; 2008 Oct; 27(46):6075-82. PubMed ID: 18591937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of copy number of c-Myc protein per cell by quantitative Western blotting.
    Rudolph C; Adam G; Simm A
    Anal Biochem; 1999 Apr; 269(1):66-71. PubMed ID: 10094776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cloning of human migfilin N-terminal domain and preparation of anti-migfilin polyclonal antibody].
    Gong W; Li J; Wang YL; Nan QZ; Jiang B; Zhang HQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):915-8. PubMed ID: 18583227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterodimeric CD3epsilongamma extracellular domain fragments: production, purification and structural analysis.
    Kim KS; Sun ZY; Wagner G; Reinherz EL
    J Mol Biol; 2000 Sep; 302(4):899-916. PubMed ID: 10993731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.
    Sarkar AK; Nuchtern JG
    Cancer Res; 2000 Apr; 60(7):1908-13. PubMed ID: 10766179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.